PRJNA375882: Comprehensive Mouse Transcriptomic BodyMap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Smarcc1
|
ENSMUSG00000032481.18 | Smarcc1 |
Fosl1
|
ENSMUSG00000024912.7 | Fosl1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Fosl1 | mm39_v1_chr19_+_5497575_5497740 | -0.56 | 3.7e-07 | Click! |
Smarcc1 | mm39_v1_chr9_+_109961079_109961170 | -0.39 | 7.5e-04 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr8_-_62576140 | 15.46 |
ENSMUST00000034052.14
ENSMUST00000034054.9 |
Anxa10
|
annexin A10 |
chr3_+_92123106 | 13.73 |
ENSMUST00000074449.7
ENSMUST00000090871.3 |
Sprr2a1
Sprr2a2
|
small proline-rich protein 2A1 small proline-rich protein 2A2 |
chr6_+_86605146 | 11.22 |
ENSMUST00000043400.9
|
Asprv1
|
aspartic peptidase, retroviral-like 1 |
chr3_-_92564232 | 10.56 |
ENSMUST00000029531.4
|
Lce1b
|
late cornified envelope 1B |
chr9_+_98372575 | 10.37 |
ENSMUST00000035029.3
|
Rbp2
|
retinol binding protein 2, cellular |
chr7_-_140856642 | 9.07 |
ENSMUST00000080654.7
ENSMUST00000167263.9 |
Cdhr5
|
cadherin-related family member 5 |
chr5_-_134975773 | 9.00 |
ENSMUST00000051401.4
|
Cldn4
|
claudin 4 |
chr15_-_101912917 | 8.93 |
ENSMUST00000023952.10
|
Krt8
|
keratin 8 |
chr16_+_33614715 | 7.73 |
ENSMUST00000023520.7
|
Muc13
|
mucin 13, epithelial transmembrane |
chr7_-_144761806 | 7.59 |
ENSMUST00000208788.2
|
Smim38
|
small integral membrane protein 38 |
chr11_-_100139728 | 7.57 |
ENSMUST00000007280.9
|
Krt16
|
keratin 16 |
chr11_+_58269862 | 7.27 |
ENSMUST00000013787.11
ENSMUST00000108826.3 |
Lypd8
|
LY6/PLAUR domain containing 8 |
chr3_-_92393193 | 7.11 |
ENSMUST00000054599.8
|
Sprr1a
|
small proline-rich protein 1A |
chr7_+_140659672 | 7.11 |
ENSMUST00000066873.5
ENSMUST00000163041.2 |
Pkp3
|
plakophilin 3 |
chr10_-_43880353 | 7.01 |
ENSMUST00000020017.14
|
Crybg1
|
crystallin beta-gamma domain containing 1 |
chr6_-_87327885 | 6.99 |
ENSMUST00000032129.3
|
Gkn1
|
gastrokine 1 |
chr1_+_182392577 | 6.72 |
ENSMUST00000048941.14
|
Capn8
|
calpain 8 |
chr11_-_100098333 | 6.57 |
ENSMUST00000007272.8
|
Krt14
|
keratin 14 |
chr3_+_90434160 | 6.49 |
ENSMUST00000199538.5
ENSMUST00000164481.7 ENSMUST00000167598.6 |
S100a14
|
S100 calcium binding protein A14 |
chr3_+_69129745 | 6.47 |
ENSMUST00000183126.2
|
Arl14
|
ADP-ribosylation factor-like 14 |
chr7_+_141988714 | 6.43 |
ENSMUST00000118276.8
ENSMUST00000105976.8 ENSMUST00000097939.9 |
Syt8
|
synaptotagmin VIII |
chr1_+_182392559 | 6.35 |
ENSMUST00000168514.7
|
Capn8
|
calpain 8 |
chr12_-_103423472 | 6.11 |
ENSMUST00000044687.7
|
Ifi27l2b
|
interferon, alpha-inducible protein 27 like 2B |
chr10_+_127541039 | 6.11 |
ENSMUST00000079590.7
|
Myo1a
|
myosin IA |
chr5_-_76511634 | 6.00 |
ENSMUST00000031146.3
|
Nmu
|
neuromedin U |
chr14_-_34077340 | 5.96 |
ENSMUST00000052126.6
|
Fam25c
|
family with sequence similarity 25, member C |
chr7_+_30487322 | 5.94 |
ENSMUST00000189673.7
ENSMUST00000190990.7 ENSMUST00000189962.7 ENSMUST00000187493.7 ENSMUST00000098559.3 |
Krtdap
|
keratinocyte differentiation associated protein |
chr10_+_18720760 | 5.90 |
ENSMUST00000019998.9
|
Perp
|
PERP, TP53 apoptosis effector |
chrX_-_7884688 | 5.85 |
ENSMUST00000033503.3
|
Glod5
|
glyoxalase domain containing 5 |
chr4_-_133329479 | 5.83 |
ENSMUST00000057311.4
|
Sfn
|
stratifin |
chr19_+_56276375 | 5.79 |
ENSMUST00000166049.8
|
Habp2
|
hyaluronic acid binding protein 2 |
chr3_+_137923521 | 5.57 |
ENSMUST00000090171.7
|
Adh7
|
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide |
chr7_+_24048613 | 5.50 |
ENSMUST00000032683.6
|
Lypd5
|
Ly6/Plaur domain containing 5 |
chr7_-_4607040 | 5.47 |
ENSMUST00000166650.3
|
Ptprh
|
protein tyrosine phosphatase, receptor type, H |
chr2_+_164790139 | 5.41 |
ENSMUST00000017881.3
|
Mmp9
|
matrix metallopeptidase 9 |
chr19_+_34044745 | 5.32 |
ENSMUST00000025682.12
ENSMUST00000126710.8 |
Lipn
|
lipase, family member N |
chr5_-_120915693 | 5.17 |
ENSMUST00000044833.9
|
Oas3
|
2'-5' oligoadenylate synthetase 3 |
chr16_+_33614378 | 5.07 |
ENSMUST00000115044.8
|
Muc13
|
mucin 13, epithelial transmembrane |
chr19_+_56276343 | 4.99 |
ENSMUST00000095948.11
|
Habp2
|
hyaluronic acid binding protein 2 |
chr6_+_68279392 | 4.99 |
ENSMUST00000103322.3
|
Igkv2-109
|
immunoglobulin kappa variable 2-109 |
chr3_+_92246440 | 4.98 |
ENSMUST00000047477.4
|
Sprr2d
|
small proline-rich protein 2D |
chr6_+_17463925 | 4.86 |
ENSMUST00000115442.8
|
Met
|
met proto-oncogene |
chr7_+_140659038 | 4.84 |
ENSMUST00000159375.8
|
Pkp3
|
plakophilin 3 |
chr2_+_24226857 | 4.81 |
ENSMUST00000114487.9
ENSMUST00000142093.7 |
Il1rn
|
interleukin 1 receptor antagonist |
chr7_+_126365506 | 4.78 |
ENSMUST00000032944.9
|
Gdpd3
|
glycerophosphodiester phosphodiesterase domain containing 3 |
chr14_-_121742659 | 4.60 |
ENSMUST00000088386.8
|
Slc15a1
|
solute carrier family 15 (oligopeptide transporter), member 1 |
chr11_+_61575245 | 4.53 |
ENSMUST00000093019.6
|
Fam83g
|
family with sequence similarity 83, member G |
chr7_+_66393252 | 4.43 |
ENSMUST00000066475.11
|
Cers3
|
ceramide synthase 3 |
chr5_-_66238313 | 4.42 |
ENSMUST00000202700.4
ENSMUST00000094757.9 ENSMUST00000113724.6 |
Rbm47
|
RNA binding motif protein 47 |
chr3_-_131196213 | 4.38 |
ENSMUST00000197057.2
|
Sgms2
|
sphingomyelin synthase 2 |
chr4_-_127251917 | 4.35 |
ENSMUST00000046498.3
|
Gjb5
|
gap junction protein, beta 5 |
chr17_-_31383976 | 4.34 |
ENSMUST00000235870.2
|
Tff1
|
trefoil factor 1 |
chr11_+_118878999 | 4.34 |
ENSMUST00000092373.13
ENSMUST00000106273.3 |
Enpp7
|
ectonucleotide pyrophosphatase/phosphodiesterase 7 |
chr9_+_98368163 | 4.28 |
ENSMUST00000189446.7
ENSMUST00000187905.7 |
Rbp2
|
retinol binding protein 2, cellular |
chr14_+_14090981 | 4.26 |
ENSMUST00000022269.7
|
Oit1
|
oncoprotein induced transcript 1 |
chr6_-_115735935 | 4.22 |
ENSMUST00000072933.13
|
Tmem40
|
transmembrane protein 40 |
chr6_-_69877961 | 4.22 |
ENSMUST00000197290.2
|
Igkv5-39
|
immunoglobulin kappa variable 5-39 |
chr4_-_127247864 | 4.21 |
ENSMUST00000106090.8
ENSMUST00000060419.2 |
Gjb4
|
gap junction protein, beta 4 |
chr18_+_82929037 | 4.20 |
ENSMUST00000236858.2
|
Zfp516
|
zinc finger protein 516 |
chr2_+_163389068 | 4.16 |
ENSMUST00000109411.8
ENSMUST00000018094.13 |
Hnf4a
|
hepatic nuclear factor 4, alpha |
chr6_+_113449237 | 4.11 |
ENSMUST00000204447.3
|
Il17rc
|
interleukin 17 receptor C |
chr6_-_70237939 | 4.09 |
ENSMUST00000103386.3
|
Igkv6-23
|
immunoglobulin kappa variable 6-23 |
chr17_+_87943401 | 4.09 |
ENSMUST00000235125.2
ENSMUST00000053577.9 ENSMUST00000234009.2 |
Epcam
|
epithelial cell adhesion molecule |
chr12_-_76842263 | 4.08 |
ENSMUST00000082431.6
|
Gpx2
|
glutathione peroxidase 2 |
chr2_-_62313981 | 4.06 |
ENSMUST00000136686.2
ENSMUST00000102733.10 |
Gcg
|
glucagon |
chrX_+_139808351 | 4.02 |
ENSMUST00000033806.5
|
Vsig1
|
V-set and immunoglobulin domain containing 1 |
chr5_+_36361360 | 4.00 |
ENSMUST00000052224.6
|
Psapl1
|
prosaposin-like 1 |
chr5_-_137919873 | 3.95 |
ENSMUST00000031741.8
|
Cyp3a13
|
cytochrome P450, family 3, subfamily a, polypeptide 13 |
chr11_+_96822213 | 3.89 |
ENSMUST00000107633.2
|
Prr15l
|
proline rich 15-like |
chr17_+_87944110 | 3.88 |
ENSMUST00000234623.2
|
Epcam
|
epithelial cell adhesion molecule |
chr5_-_100710702 | 3.87 |
ENSMUST00000097437.9
|
Plac8
|
placenta-specific 8 |
chr2_+_151414524 | 3.87 |
ENSMUST00000028950.9
|
Sdcbp2
|
syndecan binding protein (syntenin) 2 |
chr3_-_95646856 | 3.80 |
ENSMUST00000153026.8
ENSMUST00000123143.8 ENSMUST00000137912.8 ENSMUST00000029753.14 ENSMUST00000131376.8 ENSMUST00000117507.10 ENSMUST00000128885.8 ENSMUST00000147217.2 |
Ecm1
|
extracellular matrix protein 1 |
chr11_+_115225557 | 3.79 |
ENSMUST00000106543.8
ENSMUST00000019006.5 |
Otop3
|
otopetrin 3 |
chr7_+_24310171 | 3.76 |
ENSMUST00000206422.2
|
Phldb3
|
pleckstrin homology like domain, family B, member 3 |
chr14_+_51193449 | 3.73 |
ENSMUST00000095925.5
|
Pnp2
|
purine-nucleoside phosphorylase 2 |
chr4_+_118384426 | 3.72 |
ENSMUST00000030261.6
|
2610528J11Rik
|
RIKEN cDNA 2610528J11 gene |
chr7_+_28563255 | 3.69 |
ENSMUST00000138272.8
|
Lgals7
|
lectin, galactose binding, soluble 7 |
chr17_-_34218301 | 3.68 |
ENSMUST00000235463.2
|
H2-K1
|
histocompatibility 2, K1, K region |
chr6_-_70149254 | 3.66 |
ENSMUST00000197272.2
|
Igkv8-27
|
immunoglobulin kappa chain variable 8-27 |
chr5_-_88675700 | 3.64 |
ENSMUST00000087033.6
|
Jchain
|
immunoglobulin joining chain |
chr6_-_113694633 | 3.62 |
ENSMUST00000204533.3
|
Ghrl
|
ghrelin |
chr3_+_93427791 | 3.60 |
ENSMUST00000029515.5
|
S100a11
|
S100 calcium binding protein A11 |
chr10_-_127190280 | 3.60 |
ENSMUST00000059718.6
|
Inhbe
|
inhibin beta-E |
chr6_+_48881913 | 3.58 |
ENSMUST00000162948.7
ENSMUST00000167529.3 |
Aoc1
|
amine oxidase, copper-containing 1 |
chr7_-_19005721 | 3.58 |
ENSMUST00000032561.9
|
Vasp
|
vasodilator-stimulated phosphoprotein |
chr7_-_126611037 | 3.56 |
ENSMUST00000133172.2
|
Mvp
|
major vault protein |
chr6_-_115739284 | 3.56 |
ENSMUST00000166254.7
ENSMUST00000170625.8 |
Tmem40
|
transmembrane protein 40 |
chr7_+_24335969 | 3.56 |
ENSMUST00000080718.6
|
Lypd3
|
Ly6/Plaur domain containing 3 |
chr9_-_31043076 | 3.56 |
ENSMUST00000034478.3
|
St14
|
suppression of tumorigenicity 14 (colon carcinoma) |
chr6_+_30568366 | 3.55 |
ENSMUST00000049251.6
|
Cpa4
|
carboxypeptidase A4 |
chr15_-_78739717 | 3.54 |
ENSMUST00000044584.6
|
Lgals2
|
lectin, galactose-binding, soluble 2 |
chr9_+_44953723 | 3.54 |
ENSMUST00000034600.5
|
Mpzl2
|
myelin protein zero-like 2 |
chr11_+_9068098 | 3.53 |
ENSMUST00000020677.8
ENSMUST00000101525.9 |
Upp1
|
uridine phosphorylase 1 |
chr6_+_17463748 | 3.52 |
ENSMUST00000115443.8
|
Met
|
met proto-oncogene |
chr6_+_41279199 | 3.50 |
ENSMUST00000031913.5
|
Try4
|
trypsin 4 |
chr15_-_101833160 | 3.50 |
ENSMUST00000023797.8
|
Krt4
|
keratin 4 |
chr12_-_113958518 | 3.48 |
ENSMUST00000103467.2
|
Ighv14-2
|
immunoglobulin heavy variable 14-2 |
chr7_+_24069680 | 3.48 |
ENSMUST00000205428.2
ENSMUST00000171904.3 ENSMUST00000205626.2 |
Kcnn4
|
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
chr5_+_33261563 | 3.45 |
ENSMUST00000011178.5
|
Slc5a1
|
solute carrier family 5 (sodium/glucose cotransporter), member 1 |
chr6_-_69877642 | 3.43 |
ENSMUST00000103370.3
|
Igkv5-39
|
immunoglobulin kappa variable 5-39 |
chr7_+_18817767 | 3.43 |
ENSMUST00000032568.14
ENSMUST00000122999.8 ENSMUST00000108473.10 ENSMUST00000108474.2 ENSMUST00000238982.2 |
Dmpk
|
dystrophia myotonica-protein kinase |
chr13_-_41981812 | 3.42 |
ENSMUST00000223337.2
ENSMUST00000221691.2 |
Adtrp
|
androgen dependent TFPI regulating protein |
chr2_-_25129863 | 3.41 |
ENSMUST00000186719.2
ENSMUST00000043379.5 |
Cysrt1
|
cysteine rich tail 1 |
chr3_-_59102517 | 3.41 |
ENSMUST00000200095.2
|
Gpr87
|
G protein-coupled receptor 87 |
chr2_+_69210775 | 3.41 |
ENSMUST00000063690.4
|
Dhrs9
|
dehydrogenase/reductase (SDR family) member 9 |
chr3_-_88410495 | 3.39 |
ENSMUST00000120377.8
ENSMUST00000029699.13 |
Lmna
|
lamin A |
chr6_-_69704122 | 3.37 |
ENSMUST00000103364.3
|
Igkv5-48
|
immunoglobulin kappa variable 5-48 |
chr12_-_115471634 | 3.36 |
ENSMUST00000103535.3
|
Ighv1-64
|
immunoglobulin heavy variable 1-64 |
chr4_-_121182109 | 3.35 |
ENSMUST00000097905.3
|
Gm12888
|
predicted gene 12888 |
chr9_-_31375497 | 3.33 |
ENSMUST00000217007.2
ENSMUST00000213807.2 |
Tmem45b
|
transmembrane protein 45b |
chr11_+_83637766 | 3.29 |
ENSMUST00000070832.3
|
Wfdc21
|
WAP four-disulfide core domain 21 |
chr16_-_18904240 | 3.28 |
ENSMUST00000103746.3
|
Iglv1
|
immunoglobulin lambda variable 1 |
chr19_-_34143437 | 3.28 |
ENSMUST00000025686.9
|
Ankrd22
|
ankyrin repeat domain 22 |
chr2_+_110551976 | 3.24 |
ENSMUST00000090332.5
|
Muc15
|
mucin 15 |
chr1_+_106862171 | 3.21 |
ENSMUST00000081277.9
|
Serpinb12
|
serine (or cysteine) peptidase inhibitor, clade B (ovalbumin), member 12 |
chr2_+_162829250 | 3.21 |
ENSMUST00000018012.14
|
Sgk2
|
serum/glucocorticoid regulated kinase 2 |
chr15_+_80556023 | 3.21 |
ENSMUST00000023044.7
|
Fam83f
|
family with sequence similarity 83, member F |
chr9_+_46151994 | 3.20 |
ENSMUST00000034585.7
|
Apoa4
|
apolipoprotein A-IV |
chr3_-_92594516 | 3.19 |
ENSMUST00000029524.4
|
Lce1d
|
late cornified envelope 1D |
chr13_+_4283729 | 3.15 |
ENSMUST00000081326.7
|
Akr1c19
|
aldo-keto reductase family 1, member C19 |
chr14_-_56499690 | 3.12 |
ENSMUST00000015581.6
|
Gzmb
|
granzyme B |
chr19_-_32080496 | 3.09 |
ENSMUST00000235213.2
ENSMUST00000236504.2 |
Asah2
|
N-acylsphingosine amidohydrolase 2 |
chr11_+_9068134 | 3.06 |
ENSMUST00000170444.8
|
Upp1
|
uridine phosphorylase 1 |
chr13_-_41981893 | 3.05 |
ENSMUST00000137905.2
|
Adtrp
|
androgen dependent TFPI regulating protein |
chr17_-_31348576 | 3.05 |
ENSMUST00000024827.5
|
Tff3
|
trefoil factor 3, intestinal |
chr7_-_19415301 | 3.04 |
ENSMUST00000150569.9
ENSMUST00000127648.4 ENSMUST00000003071.10 |
Gm44805
Apoc4
|
predicted gene 44805 apolipoprotein C-IV |
chr7_-_19684654 | 3.04 |
ENSMUST00000043440.8
|
Igsf23
|
immunoglobulin superfamily, member 23 |
chr3_+_94249399 | 3.03 |
ENSMUST00000029794.11
|
Them5
|
thioesterase superfamily member 5 |
chr4_+_43506966 | 3.03 |
ENSMUST00000030183.10
|
Car9
|
carbonic anhydrase 9 |
chr3_-_88243455 | 3.01 |
ENSMUST00000193872.2
|
Tmem79
|
transmembrane protein 79 |
chr17_+_35268942 | 2.97 |
ENSMUST00000007257.10
|
Clic1
|
chloride intracellular channel 1 |
chr6_-_70121150 | 2.97 |
ENSMUST00000197525.2
|
Igkv8-28
|
immunoglobulin kappa variable 8-28 |
chr8_+_105688344 | 2.96 |
ENSMUST00000043183.8
|
Ces2g
|
carboxylesterase 2G |
chr2_+_110551927 | 2.96 |
ENSMUST00000111017.9
|
Muc15
|
mucin 15 |
chr2_+_119067832 | 2.95 |
ENSMUST00000028783.14
|
Spint1
|
serine protease inhibitor, Kunitz type 1 |
chr2_+_110551685 | 2.95 |
ENSMUST00000111016.9
|
Muc15
|
mucin 15 |
chr2_+_119068012 | 2.93 |
ENSMUST00000110817.3
|
Spint1
|
serine protease inhibitor, Kunitz type 1 |
chr6_-_3494587 | 2.93 |
ENSMUST00000049985.15
|
Hepacam2
|
HEPACAM family member 2 |
chr9_+_108216466 | 2.90 |
ENSMUST00000193987.2
|
Gpx1
|
glutathione peroxidase 1 |
chr16_-_56652241 | 2.89 |
ENSMUST00000135672.2
|
Tmem45a
|
transmembrane protein 45a |
chr2_+_119067929 | 2.88 |
ENSMUST00000110816.8
|
Spint1
|
serine protease inhibitor, Kunitz type 1 |
chr10_-_128425519 | 2.86 |
ENSMUST00000082059.7
|
Erbb3
|
erb-b2 receptor tyrosine kinase 3 |
chr12_-_113223839 | 2.85 |
ENSMUST00000194738.6
ENSMUST00000178282.3 |
Igha
|
immunoglobulin heavy constant alpha |
chr3_+_92315290 | 2.84 |
ENSMUST00000047264.3
|
Sprr2i
|
small proline-rich protein 2I |
chr7_+_119773070 | 2.83 |
ENSMUST00000033201.7
|
Anks4b
|
ankyrin repeat and sterile alpha motif domain containing 4B |
chr1_+_106788873 | 2.81 |
ENSMUST00000086701.13
ENSMUST00000188745.3 ENSMUST00000112730.8 |
Serpinb5
|
serine (or cysteine) peptidase inhibitor, clade B, member 5 |
chr9_-_99599312 | 2.78 |
ENSMUST00000112882.9
ENSMUST00000131922.2 |
Cldn18
|
claudin 18 |
chr5_-_87054796 | 2.76 |
ENSMUST00000031181.16
ENSMUST00000113333.2 |
Ugt2b34
|
UDP glucuronosyltransferase 2 family, polypeptide B34 |
chr14_+_51181956 | 2.75 |
ENSMUST00000178092.2
ENSMUST00000227052.2 |
Pnp
Gm49342
|
purine-nucleoside phosphorylase predicted gene, 49342 |
chr2_+_143757193 | 2.73 |
ENSMUST00000103172.4
|
Dstn
|
destrin |
chr17_-_34736326 | 2.72 |
ENSMUST00000075483.5
|
Btnl6
|
butyrophilin-like 6 |
chr1_+_107350411 | 2.72 |
ENSMUST00000086690.6
|
Serpinb7
|
serine (or cysteine) peptidase inhibitor, clade B, member 7 |
chr1_-_136158027 | 2.71 |
ENSMUST00000150163.8
ENSMUST00000144464.7 |
Inava
|
innate immunity activator |
chr18_+_20691095 | 2.71 |
ENSMUST00000059787.15
ENSMUST00000120102.8 |
Dsg2
|
desmoglein 2 |
chr17_+_37209002 | 2.71 |
ENSMUST00000078438.5
|
Trim31
|
tripartite motif-containing 31 |
chr13_-_32522548 | 2.70 |
ENSMUST00000041859.9
|
Gmds
|
GDP-mannose 4, 6-dehydratase |
chr3_-_92672367 | 2.70 |
ENSMUST00000051521.5
|
Lce1h
|
late cornified envelope 1H |
chr11_-_99383938 | 2.69 |
ENSMUST00000006969.8
|
Krt23
|
keratin 23 |
chr14_-_55995912 | 2.68 |
ENSMUST00000001497.9
|
Cideb
|
cell death-inducing DNA fragmentation factor, alpha subunit-like effector B |
chr17_-_57289121 | 2.68 |
ENSMUST00000056113.5
|
Acer1
|
alkaline ceramidase 1 |
chr15_+_75734159 | 2.67 |
ENSMUST00000023238.6
ENSMUST00000230514.2 ENSMUST00000229331.2 |
Gsdmd
|
gasdermin D |
chr3_+_106393348 | 2.67 |
ENSMUST00000183271.2
|
Dennd2d
|
DENN/MADD domain containing 2D |
chr6_+_68247469 | 2.65 |
ENSMUST00000103321.3
|
Igkv1-110
|
immunoglobulin kappa variable 1-110 |
chr6_-_70194405 | 2.65 |
ENSMUST00000103384.2
|
Igkv8-24
|
immunoglobulin kappa chain variable 8-24 |
chr7_+_140414837 | 2.64 |
ENSMUST00000106050.8
|
Urah
|
urate (5-hydroxyiso-) hydrolase |
chr7_-_28947882 | 2.64 |
ENSMUST00000032808.6
|
2200002D01Rik
|
RIKEN cDNA 2200002D01 gene |
chr1_+_172328768 | 2.64 |
ENSMUST00000111228.2
|
Tagln2
|
transgelin 2 |
chr10_+_79656823 | 2.62 |
ENSMUST00000169041.9
|
Misp
|
mitotic spindle positioning |
chr3_+_92223927 | 2.60 |
ENSMUST00000061038.4
|
Sprr2b
|
small proline-rich protein 2B |
chr12_-_114023935 | 2.59 |
ENSMUST00000103469.4
|
Ighv14-3
|
immunoglobulin heavy variable V14-3 |
chr9_+_108216433 | 2.58 |
ENSMUST00000191997.2
|
Gpx1
|
glutathione peroxidase 1 |
chr15_-_83135920 | 2.58 |
ENSMUST00000229687.2
ENSMUST00000164614.3 ENSMUST00000049530.14 |
A4galt
|
alpha 1,4-galactosyltransferase |
chr19_-_4548602 | 2.56 |
ENSMUST00000048482.8
|
2010003K11Rik
|
RIKEN cDNA 2010003K11 gene |
chr4_+_118384183 | 2.56 |
ENSMUST00000106367.8
|
2610528J11Rik
|
RIKEN cDNA 2610528J11 gene |
chr8_-_62044164 | 2.55 |
ENSMUST00000135439.2
ENSMUST00000121200.9 |
Palld
|
palladin, cytoskeletal associated protein |
chr2_+_122129379 | 2.54 |
ENSMUST00000028656.2
|
Duoxa2
|
dual oxidase maturation factor 2 |
chr3_-_10273628 | 2.54 |
ENSMUST00000029041.6
|
Fabp4
|
fatty acid binding protein 4, adipocyte |
chr8_+_22145796 | 2.54 |
ENSMUST00000079528.6
|
Defa17
|
defensin, alpha, 17 |
chr9_-_45115381 | 2.53 |
ENSMUST00000034599.15
|
Tmprss4
|
transmembrane protease, serine 4 |
chr5_-_134776101 | 2.51 |
ENSMUST00000015138.13
|
Eln
|
elastin |
chrX_-_73325318 | 2.50 |
ENSMUST00000239458.2
ENSMUST00000019232.10 |
Dnase1l1
|
deoxyribonuclease 1-like 1 |
chr14_+_14091030 | 2.49 |
ENSMUST00000224529.2
|
Oit1
|
oncoprotein induced transcript 1 |
chr8_-_4155758 | 2.48 |
ENSMUST00000138439.2
ENSMUST00000145007.8 |
Cd209f
|
CD209f antigen |
chr1_+_180878797 | 2.47 |
ENSMUST00000036819.7
|
9130409I23Rik
|
RIKEN cDNA 9130409I23 gene |
chr1_-_10790120 | 2.46 |
ENSMUST00000035577.7
|
Cpa6
|
carboxypeptidase A6 |
chr4_-_4077510 | 2.43 |
ENSMUST00000108383.2
|
Sdr16c6
|
short chain dehydrogenase/reductase family 16C, member 6 |
chr14_-_34032311 | 2.42 |
ENSMUST00000111917.3
ENSMUST00000228704.2 |
Shld2
|
shieldin complex subunit 2 |
chr9_+_69361348 | 2.42 |
ENSMUST00000134907.8
|
Anxa2
|
annexin A2 |
chr6_-_72496986 | 2.41 |
ENSMUST00000160123.9
ENSMUST00000234038.2 ENSMUST00000235004.2 |
Sh2d6
|
SH2 domain containing 6 |
chr18_+_20691278 | 2.40 |
ENSMUST00000121837.2
|
Dsg2
|
desmoglein 2 |
chr8_-_21817031 | 2.38 |
ENSMUST00000098890.4
|
Defa29
|
defensin, alpha, 29 |
chr1_-_135186176 | 2.38 |
ENSMUST00000185752.2
ENSMUST00000003135.14 |
Elf3
|
E74-like factor 3 |
chr8_+_21868531 | 2.38 |
ENSMUST00000170275.4
|
Defa2
|
defensin, alpha, 2 |
chr3_-_92926364 | 2.38 |
ENSMUST00000193944.2
ENSMUST00000029520.9 |
Lce1m
|
late cornified envelope 1M |
chr15_-_75886166 | 2.37 |
ENSMUST00000060807.12
|
Fam83h
|
family with sequence similarity 83, member H |
chr8_-_21946576 | 2.36 |
ENSMUST00000110752.4
|
Defa42
|
defensin, alpha, 42 |
chr6_-_69741999 | 2.35 |
ENSMUST00000103365.3
|
Igkv12-46
|
immunoglobulin kappa variable 12-46 |
chr4_-_129121676 | 2.35 |
ENSMUST00000106051.8
|
C77080
|
expressed sequence C77080 |
chr6_+_78402956 | 2.35 |
ENSMUST00000079926.6
|
Reg1
|
regenerating islet-derived 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.4 | 9.6 | GO:0009609 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
2.4 | 11.9 | GO:1904970 | brush border assembly(GO:1904970) |
2.2 | 6.6 | GO:0046108 | uridine catabolic process(GO:0006218) uridine metabolic process(GO:0046108) |
2.2 | 8.8 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
2.2 | 13.1 | GO:0002159 | desmosome assembly(GO:0002159) |
1.9 | 5.8 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
1.8 | 5.4 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
1.7 | 5.1 | GO:0003165 | Purkinje myocyte development(GO:0003165) |
1.6 | 14.6 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
1.6 | 4.8 | GO:0097184 | amiloride transport(GO:0015898) cellular response to copper ion starvation(GO:0035874) response to azide(GO:0097184) cellular response to azide(GO:0097185) |
1.5 | 10.4 | GO:0070495 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
1.4 | 5.6 | GO:0006069 | ethanol oxidation(GO:0006069) |
1.4 | 4.2 | GO:0010534 | regulation of activation of JAK2 kinase activity(GO:0010534) activation of JAK2 kinase activity(GO:0042977) negative regulation of activation of JAK2 kinase activity(GO:1902569) |
1.4 | 4.1 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
1.2 | 6.2 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
1.2 | 6.0 | GO:0002484 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
1.2 | 3.6 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
1.1 | 2.2 | GO:0002777 | antimicrobial peptide biosynthetic process(GO:0002777) antibacterial peptide biosynthetic process(GO:0002780) |
1.1 | 18.6 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
1.1 | 4.3 | GO:2000563 | positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
1.1 | 3.2 | GO:0034443 | negative regulation of lipoprotein oxidation(GO:0034443) multicellular organism lipid catabolic process(GO:0044240) |
1.0 | 4.1 | GO:0051673 | membrane disruption in other organism(GO:0051673) |
1.0 | 21.3 | GO:0061436 | establishment of skin barrier(GO:0061436) |
1.0 | 3.0 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
1.0 | 2.0 | GO:0070055 | mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response(GO:0030969) mRNA splicing, via endonucleolytic cleavage and ligation(GO:0070054) mRNA endonucleolytic cleavage involved in unfolded protein response(GO:0070055) |
1.0 | 5.9 | GO:0002934 | desmosome organization(GO:0002934) |
1.0 | 1.0 | GO:0042335 | cuticle development(GO:0042335) |
1.0 | 4.8 | GO:0072139 | glomerular parietal epithelial cell differentiation(GO:0072139) |
0.9 | 4.7 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.9 | 2.8 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.9 | 2.7 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
0.9 | 3.6 | GO:1904344 | regulation of gastric mucosal blood circulation(GO:1904344) positive regulation of gastric mucosal blood circulation(GO:1904346) gastric mucosal blood circulation(GO:1990768) negative regulation of energy homeostasis(GO:2000506) |
0.9 | 3.6 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.9 | 1.8 | GO:1902567 | negative regulation of eosinophil activation(GO:1902567) |
0.9 | 5.3 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.9 | 57.0 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.8 | 5.0 | GO:0032804 | negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) |
0.8 | 2.5 | GO:2000469 | regulation of peroxidase activity(GO:2000468) negative regulation of peroxidase activity(GO:2000469) |
0.8 | 2.5 | GO:0097037 | heme export(GO:0097037) |
0.8 | 2.3 | GO:0018146 | keratan sulfate biosynthetic process(GO:0018146) |
0.8 | 4.6 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.8 | 3.8 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.7 | 2.2 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.7 | 2.2 | GO:0045645 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
0.7 | 4.4 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.7 | 2.1 | GO:0071846 | actin filament debranching(GO:0071846) |
0.7 | 6.2 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.7 | 4.1 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.7 | 2.0 | GO:0051977 | lysophospholipid transport(GO:0051977) |
0.7 | 1.4 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
0.7 | 4.6 | GO:0042938 | dipeptide transport(GO:0042938) |
0.7 | 2.6 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.6 | 1.9 | GO:0030070 | insulin processing(GO:0030070) |
0.6 | 5.2 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.6 | 5.0 | GO:0031179 | peptide modification(GO:0031179) leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
0.6 | 3.1 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.6 | 4.9 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.6 | 1.2 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.6 | 3.6 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.6 | 1.8 | GO:0033624 | cerebellar cortex structural organization(GO:0021698) regulation of Rap protein signal transduction(GO:0032487) negative regulation of integrin activation(GO:0033624) |
0.6 | 2.4 | GO:0009804 | coumarin metabolic process(GO:0009804) coumarin catabolic process(GO:0046226) |
0.6 | 1.8 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
0.6 | 0.6 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
0.6 | 2.9 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.6 | 2.3 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.6 | 3.4 | GO:0045062 | extrathymic T cell selection(GO:0045062) |
0.6 | 2.8 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.5 | 1.1 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.5 | 2.2 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.5 | 3.2 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.5 | 1.6 | GO:0097535 | lymphoid lineage cell migration(GO:0097534) lymphoid lineage cell migration into thymus(GO:0097535) |
0.5 | 8.8 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.5 | 2.0 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.5 | 3.0 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.5 | 2.5 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.5 | 6.4 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.5 | 3.4 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.5 | 1.9 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.5 | 2.4 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.5 | 1.0 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.5 | 0.9 | GO:0035627 | ceramide transport(GO:0035627) |
0.5 | 1.4 | GO:1901082 | positive regulation of hindgut contraction(GO:0060450) regulation of relaxation of smooth muscle(GO:1901080) positive regulation of relaxation of smooth muscle(GO:1901082) |
0.5 | 2.8 | GO:1903490 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
0.5 | 2.3 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.5 | 2.7 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.5 | 1.4 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.4 | 0.9 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.4 | 3.6 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.4 | 3.9 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.4 | 0.9 | GO:1901003 | negative regulation of fermentation(GO:1901003) |
0.4 | 1.3 | GO:2001176 | mediator complex assembly(GO:0036034) DNA replication preinitiation complex assembly(GO:0071163) response to sorbitol(GO:0072708) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
0.4 | 1.3 | GO:0042128 | nitrate assimilation(GO:0042128) |
0.4 | 4.3 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.4 | 3.0 | GO:0015862 | uridine transport(GO:0015862) |
0.4 | 3.0 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
0.4 | 1.3 | GO:0070839 | divalent metal ion export(GO:0070839) |
0.4 | 1.2 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.4 | 2.8 | GO:2001205 | negative regulation of osteoclast development(GO:2001205) |
0.4 | 5.9 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.4 | 1.2 | GO:2000416 | regulation of eosinophil migration(GO:2000416) positive regulation of eosinophil migration(GO:2000418) |
0.4 | 2.8 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.4 | 1.2 | GO:1904582 | positive regulation of intracellular mRNA localization(GO:1904582) |
0.4 | 0.4 | GO:0032754 | positive regulation of interleukin-5 production(GO:0032754) positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.4 | 1.2 | GO:0048817 | negative regulation of hair follicle maturation(GO:0048817) |
0.4 | 1.2 | GO:2000547 | regulation of dendritic cell dendrite assembly(GO:2000547) |
0.4 | 0.8 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.4 | 0.8 | GO:0060264 | regulation of respiratory burst involved in inflammatory response(GO:0060264) negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
0.4 | 0.8 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.4 | 3.0 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.4 | 1.5 | GO:0001970 | positive regulation of activation of membrane attack complex(GO:0001970) |
0.4 | 2.3 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.4 | 1.1 | GO:0071608 | macrophage inflammatory protein-1 alpha production(GO:0071608) regulation of macrophage inflammatory protein 1 alpha production(GO:0071640) |
0.4 | 2.2 | GO:0001575 | globoside metabolic process(GO:0001575) |
0.4 | 1.1 | GO:0070904 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
0.4 | 3.6 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.4 | 1.5 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.4 | 1.4 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.3 | 1.0 | GO:0033082 | regulation of extrathymic T cell differentiation(GO:0033082) |
0.3 | 2.8 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.3 | 1.0 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.3 | 5.5 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
0.3 | 2.0 | GO:0097283 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.3 | 0.7 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.3 | 2.0 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.3 | 1.7 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.3 | 1.7 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.3 | 2.3 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.3 | 2.6 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.3 | 1.0 | GO:0046032 | ADP catabolic process(GO:0046032) |
0.3 | 1.3 | GO:0006168 | adenine salvage(GO:0006168) purine nucleobase salvage(GO:0043096) adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.3 | 1.6 | GO:1902732 | positive regulation of chondrocyte proliferation(GO:1902732) |
0.3 | 1.3 | GO:1904207 | regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
0.3 | 1.3 | GO:0071226 | cellular response to molecule of fungal origin(GO:0071226) |
0.3 | 1.3 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.3 | 0.9 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.3 | 0.9 | GO:0018900 | dichloromethane metabolic process(GO:0018900) |
0.3 | 1.6 | GO:0002268 | follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
0.3 | 3.1 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.3 | 4.3 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.3 | 1.2 | GO:0090096 | lactic acid secretion(GO:0046722) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
0.3 | 6.1 | GO:0002251 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.3 | 0.9 | GO:0071938 | vitamin A transport(GO:0071938) vitamin A import(GO:0071939) |
0.3 | 1.2 | GO:0021502 | neural fold elevation formation(GO:0021502) |
0.3 | 1.5 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
0.3 | 2.7 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.3 | 2.1 | GO:1900141 | regulation of oligodendrocyte apoptotic process(GO:1900141) negative regulation of oligodendrocyte apoptotic process(GO:1900142) regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
0.3 | 0.9 | GO:1904633 | glomerular visceral epithelial cell apoptotic process(GO:1903210) regulation of glomerular visceral epithelial cell apoptotic process(GO:1904633) positive regulation of glomerular visceral epithelial cell apoptotic process(GO:1904635) positive regulation of progesterone biosynthetic process(GO:2000184) |
0.3 | 1.5 | GO:0097101 | arterial endothelial cell fate commitment(GO:0060844) blood vessel endothelial cell fate commitment(GO:0060846) Notch signaling pathway involved in arterial endothelial cell fate commitment(GO:0060853) blood vessel endothelial cell fate specification(GO:0097101) positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901297) positive regulation of canonical Wnt signaling pathway involved in heart development(GO:1905068) |
0.3 | 0.9 | GO:0072356 | chromosome passenger complex localization to kinetochore(GO:0072356) |
0.3 | 1.8 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.3 | 5.5 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.3 | 1.2 | GO:0036233 | glycine import(GO:0036233) |
0.3 | 1.7 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.3 | 0.9 | GO:0097401 | synaptic vesicle lumen acidification(GO:0097401) |
0.3 | 1.1 | GO:0035973 | aggrephagy(GO:0035973) |
0.3 | 0.6 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.3 | 2.0 | GO:0031161 | phosphatidylinositol catabolic process(GO:0031161) |
0.3 | 4.2 | GO:0042048 | olfactory behavior(GO:0042048) |
0.3 | 1.9 | GO:1902019 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.3 | 1.7 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.3 | 1.6 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
0.3 | 5.7 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.3 | 1.4 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.3 | 0.8 | GO:0060468 | negative regulation of fertilization(GO:0060467) prevention of polyspermy(GO:0060468) |
0.3 | 1.9 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.3 | 0.8 | GO:0060464 | lung lobe formation(GO:0060464) diaphragm morphogenesis(GO:0060540) |
0.3 | 0.8 | GO:0006530 | asparagine catabolic process(GO:0006530) |
0.3 | 1.1 | GO:0010911 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
0.3 | 3.4 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.3 | 0.8 | GO:0097052 | L-kynurenine metabolic process(GO:0097052) |
0.3 | 1.5 | GO:0009624 | response to nematode(GO:0009624) |
0.3 | 0.8 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.3 | 0.8 | GO:0071503 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) regulation of midbrain dopaminergic neuron differentiation(GO:1904956) regulation of planar cell polarity pathway involved in axis elongation(GO:2000040) negative regulation of planar cell polarity pathway involved in axis elongation(GO:2000041) |
0.2 | 1.7 | GO:0072719 | cellular response to cisplatin(GO:0072719) |
0.2 | 1.5 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.2 | 1.7 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.2 | 1.0 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
0.2 | 2.0 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.2 | 1.5 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.2 | 0.7 | GO:1903632 | positive regulation of aminoacyl-tRNA ligase activity(GO:1903632) |
0.2 | 0.7 | GO:0045950 | negative regulation of mitotic recombination(GO:0045950) |
0.2 | 1.2 | GO:0003349 | epicardium-derived cardiac endothelial cell differentiation(GO:0003349) epicardium-derived cardiac vascular smooth muscle cell differentiation(GO:0060983) |
0.2 | 0.9 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.2 | 0.9 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
0.2 | 0.7 | GO:0060720 | spongiotrophoblast cell proliferation(GO:0060720) cell proliferation involved in embryonic placenta development(GO:0060722) |
0.2 | 0.9 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.2 | 0.9 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.2 | 0.7 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.2 | 6.0 | GO:0032060 | bleb assembly(GO:0032060) |
0.2 | 0.7 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.2 | 1.8 | GO:0035879 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.2 | 1.1 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.2 | 0.4 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.2 | 1.8 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.2 | 15.6 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.2 | 1.1 | GO:0015888 | thiamine transport(GO:0015888) |
0.2 | 3.6 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.2 | 2.8 | GO:0033089 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.2 | 3.6 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.2 | 0.6 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
0.2 | 0.6 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.2 | 1.9 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.2 | 2.1 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.2 | 50.3 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.2 | 1.2 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.2 | 25.7 | GO:0007586 | digestion(GO:0007586) |
0.2 | 1.8 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.2 | 1.4 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
0.2 | 0.6 | GO:0019417 | sulfur oxidation(GO:0019417) |
0.2 | 0.6 | GO:2000872 | positive regulation of progesterone secretion(GO:2000872) |
0.2 | 1.8 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.2 | 3.0 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.2 | 0.8 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
0.2 | 1.6 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.2 | 4.9 | GO:0048385 | regulation of retinoic acid receptor signaling pathway(GO:0048385) |
0.2 | 0.8 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
0.2 | 0.6 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.2 | 1.0 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.2 | 1.1 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
0.2 | 1.9 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.2 | 4.5 | GO:0019430 | removal of superoxide radicals(GO:0019430) |
0.2 | 0.7 | GO:0009597 | detection of virus(GO:0009597) |
0.2 | 3.7 | GO:2000404 | regulation of T cell migration(GO:2000404) |
0.2 | 2.4 | GO:0006026 | aminoglycan catabolic process(GO:0006026) |
0.2 | 0.6 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
0.2 | 0.7 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.2 | 2.4 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.2 | 11.9 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.2 | 0.5 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.2 | 1.1 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
0.2 | 1.3 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
0.2 | 0.4 | GO:1900135 | positive regulation of renin secretion into blood stream(GO:1900135) |
0.2 | 0.4 | GO:0038096 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
0.2 | 1.2 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.2 | 0.9 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.2 | 0.5 | GO:0014908 | myotube differentiation involved in skeletal muscle regeneration(GO:0014908) |
0.2 | 0.9 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) |
0.2 | 0.2 | GO:0002085 | inhibition of neuroepithelial cell differentiation(GO:0002085) |
0.2 | 0.5 | GO:0042376 | menaquinone metabolic process(GO:0009233) phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.2 | 1.5 | GO:0032740 | positive regulation of interleukin-17 production(GO:0032740) |
0.2 | 0.7 | GO:0046512 | sphingosine biosynthetic process(GO:0046512) |
0.2 | 0.9 | GO:0043056 | forward locomotion(GO:0043056) |
0.2 | 0.2 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.2 | 0.5 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.2 | 2.5 | GO:0003334 | keratinocyte development(GO:0003334) |
0.2 | 0.5 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
0.2 | 1.0 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.2 | 0.3 | GO:0071211 | protein targeting to vacuole involved in autophagy(GO:0071211) |
0.2 | 3.0 | GO:0060056 | mammary gland involution(GO:0060056) |
0.2 | 1.3 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.2 | 1.3 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.2 | 2.3 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.2 | 0.8 | GO:0006116 | NADH oxidation(GO:0006116) |
0.2 | 0.7 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.2 | 2.4 | GO:0045821 | positive regulation of glycolytic process(GO:0045821) |
0.2 | 1.1 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.2 | 0.5 | GO:1900477 | negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter(GO:1900477) |
0.2 | 3.4 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.2 | 0.2 | GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) notochord regression(GO:0060032) |
0.2 | 0.5 | GO:0097272 | ammonia homeostasis(GO:0097272) |
0.2 | 4.0 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.2 | 1.3 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.2 | 0.3 | GO:0010710 | regulation of collagen catabolic process(GO:0010710) |
0.2 | 0.5 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.2 | 0.9 | GO:0090005 | protein depalmitoylation(GO:0002084) negative regulation of Golgi to plasma membrane protein transport(GO:0042997) negative regulation of establishment of protein localization to plasma membrane(GO:0090005) macromolecule depalmitoylation(GO:0098734) |
0.2 | 1.1 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.2 | 2.5 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.2 | 0.9 | GO:0001794 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
0.2 | 1.8 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.2 | 0.5 | GO:1904766 | negative regulation of macroautophagy by TORC1 signaling(GO:1904766) |
0.2 | 0.9 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.2 | 2.1 | GO:0001516 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.2 | 2.1 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 1.0 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 1.8 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.1 | 1.0 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.1 | 0.7 | GO:2000484 | positive regulation of interleukin-8 secretion(GO:2000484) |
0.1 | 0.9 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.1 | 1.6 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.3 | GO:0035793 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) cell migration involved in metanephros development(GO:0035788) metanephric mesenchymal cell migration(GO:0035789) positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) regulation of metanephric mesenchymal cell migration(GO:2000589) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
0.1 | 1.9 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) |
0.1 | 0.4 | GO:2000813 | actin filament uncapping(GO:0051695) negative regulation of barbed-end actin filament capping(GO:2000813) |
0.1 | 1.2 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.1 | 0.4 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.1 | 0.1 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.1 | 0.3 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 0.4 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
0.1 | 0.6 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.1 | 1.1 | GO:0009644 | response to high light intensity(GO:0009644) |
0.1 | 0.4 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
0.1 | 0.7 | GO:0061760 | antifungal innate immune response(GO:0061760) regulation of antifungal innate immune response(GO:1905034) negative regulation of antifungal innate immune response(GO:1905035) |
0.1 | 18.6 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.1 | 1.1 | GO:0044805 | late nucleophagy(GO:0044805) |
0.1 | 0.7 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.1 | 0.8 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.1 | 0.5 | GO:1904569 | regulation of selenocysteine incorporation(GO:1904569) |
0.1 | 1.1 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.1 | 2.8 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.1 | 0.3 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.1 | 2.2 | GO:0060736 | prostate gland growth(GO:0060736) |
0.1 | 0.4 | GO:1904414 | neural plate mediolateral regionalization(GO:0021998) mesoderm structural organization(GO:0048338) paraxial mesoderm structural organization(GO:0048352) positive regulation of cardiac ventricle development(GO:1904414) |
0.1 | 0.3 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.1 | 4.2 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.1 | 1.2 | GO:0040031 | snRNA modification(GO:0040031) |
0.1 | 1.0 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.1 | 0.8 | GO:0044597 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.1 | 0.4 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.1 | 0.4 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.1 | 0.5 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
0.1 | 0.7 | GO:1990839 | response to endothelin(GO:1990839) |
0.1 | 1.0 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 0.6 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.1 | 3.9 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.1 | 2.3 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.1 | 0.5 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
0.1 | 1.7 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.1 | 6.0 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.1 | 0.4 | GO:0042262 | DNA protection(GO:0042262) dATP catabolic process(GO:0046061) |
0.1 | 1.1 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.1 | 2.0 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.4 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 1.2 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 0.8 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.5 | GO:0031204 | posttranslational protein targeting to membrane, translocation(GO:0031204) |
0.1 | 5.3 | GO:0007340 | acrosome reaction(GO:0007340) |
0.1 | 0.8 | GO:0051132 | NK T cell activation(GO:0051132) |
0.1 | 0.6 | GO:0021506 | anterior neuropore closure(GO:0021506) neuropore closure(GO:0021995) |
0.1 | 1.6 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 3.4 | GO:1905145 | acetylcholine receptor signaling pathway(GO:0095500) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.1 | 1.4 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.1 | 0.6 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.1 | 0.5 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.1 | 0.7 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.1 | 0.9 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.1 | 1.5 | GO:0060426 | lung vasculature development(GO:0060426) |
0.1 | 3.6 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.1 | 0.3 | GO:1903027 | regulation of opsonization(GO:1903027) positive regulation of opsonization(GO:1903028) |
0.1 | 5.2 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.1 | 0.9 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.1 | 0.7 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.1 | 0.6 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.1 | 1.4 | GO:1990403 | embryonic brain development(GO:1990403) |
0.1 | 0.5 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
0.1 | 0.9 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.1 | 2.8 | GO:0060512 | prostate gland morphogenesis(GO:0060512) |
0.1 | 0.4 | GO:0070650 | actin filament bundle distribution(GO:0070650) |
0.1 | 0.7 | GO:0019883 | antigen processing and presentation of endogenous antigen(GO:0019883) |
0.1 | 0.4 | GO:0003383 | apical constriction(GO:0003383) |
0.1 | 0.4 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
0.1 | 1.0 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 0.3 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.1 | 0.4 | GO:0033580 | protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
0.1 | 4.4 | GO:0048146 | positive regulation of fibroblast proliferation(GO:0048146) |
0.1 | 0.6 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.1 | 0.8 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.4 | GO:0060005 | vestibular reflex(GO:0060005) |
0.1 | 2.3 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.1 | 0.4 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.1 | 0.2 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.1 | 0.9 | GO:0032823 | regulation of natural killer cell differentiation(GO:0032823) positive regulation of natural killer cell differentiation(GO:0032825) |
0.1 | 0.4 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.1 | 0.6 | GO:0042167 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.1 | 1.6 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.1 | 1.4 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.1 | 0.8 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.1 | 1.3 | GO:0042633 | molting cycle(GO:0042303) hair cycle(GO:0042633) |
0.1 | 0.2 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
0.1 | 0.5 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.1 | 1.3 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 0.9 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.1 | 0.6 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.1 | 0.2 | GO:1904630 | negative regulation of interleukin-12 biosynthetic process(GO:0045083) response to diterpene(GO:1904629) cellular response to diterpene(GO:1904630) response to glucoside(GO:1904631) cellular response to glucoside(GO:1904632) |
0.1 | 0.9 | GO:0060749 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.1 | 0.5 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.1 | 0.9 | GO:2001199 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
0.1 | 2.8 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.1 | 0.2 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
0.1 | 0.3 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.1 | 0.3 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.1 | 0.9 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.1 | 1.4 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.1 | 0.4 | GO:0071718 | sodium-independent icosanoid transport(GO:0071718) |
0.1 | 1.2 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 0.6 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.1 | 0.5 | GO:0002664 | regulation of T cell tolerance induction(GO:0002664) |
0.1 | 0.4 | GO:0060594 | mammary gland specification(GO:0060594) |
0.1 | 2.0 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.1 | 0.2 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.1 | 0.8 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.6 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 0.5 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 0.2 | GO:0003167 | atrioventricular bundle cell differentiation(GO:0003167) His-Purkinje system cell differentiation(GO:0060932) |
0.1 | 1.2 | GO:0031639 | plasminogen activation(GO:0031639) |
0.1 | 0.6 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.1 | 2.5 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.1 | 0.3 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.1 | 0.3 | GO:0043328 | protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.1 | 0.6 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) phosphatidylethanolamine metabolic process(GO:0046337) |
0.1 | 0.7 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.7 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
0.1 | 0.5 | GO:0051697 | protein delipidation(GO:0051697) |
0.1 | 1.6 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.1 | 0.7 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.1 | 0.8 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.1 | 0.3 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.1 | 0.3 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.7 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 0.4 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.1 | 0.2 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.1 | 0.1 | GO:0033026 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) negative regulation of mast cell apoptotic process(GO:0033026) |
0.1 | 1.4 | GO:0035634 | response to stilbenoid(GO:0035634) |
0.1 | 0.2 | GO:0019532 | oxalate transport(GO:0019532) |
0.1 | 0.2 | GO:1901723 | thorax and anterior abdomen determination(GO:0007356) adrenal cortex development(GO:0035801) adrenal cortex formation(GO:0035802) negative regulation of glomerular mesangial cell proliferation(GO:0072125) metanephric comma-shaped body morphogenesis(GO:0072278) negative regulation of metanephric glomerulus development(GO:0072299) regulation of metanephric glomerular mesangial cell proliferation(GO:0072301) negative regulation of metanephric glomerular mesangial cell proliferation(GO:0072302) negative regulation of glomerulus development(GO:0090194) negative regulation of cell proliferation involved in kidney development(GO:1901723) regulation of metanephric ureteric bud development(GO:2001074) positive regulation of metanephric ureteric bud development(GO:2001076) |
0.1 | 4.3 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.1 | 0.3 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.1 | 0.1 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.1 | 0.2 | GO:0046436 | D-serine catabolic process(GO:0036088) D-alanine family amino acid metabolic process(GO:0046144) D-alanine metabolic process(GO:0046436) D-alanine catabolic process(GO:0055130) |
0.1 | 0.2 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
0.1 | 0.6 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.1 | 3.0 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.1 | 2.8 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
0.1 | 0.5 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.1 | 0.5 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.1 | 0.5 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.1 | 2.4 | GO:0033077 | T cell differentiation in thymus(GO:0033077) thymocyte aggregation(GO:0071594) |
0.1 | 0.8 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
0.1 | 0.9 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.1 | 0.7 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.1 | 0.9 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.1 | 0.5 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.1 | 1.0 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.1 | 0.5 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.1 | 0.1 | GO:0048822 | enucleate erythrocyte development(GO:0048822) |
0.1 | 0.6 | GO:0051014 | actin filament severing(GO:0051014) |
0.1 | 0.6 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.6 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.1 | 0.4 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.1 | 0.6 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.1 | 0.9 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.1 | 0.3 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
0.1 | 0.2 | GO:1990091 | positive regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014718) sodium-dependent self proteolysis(GO:1990091) |
0.1 | 9.9 | GO:0043588 | skin development(GO:0043588) |
0.1 | 2.6 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.1 | 0.2 | GO:1902221 | L-phenylalanine metabolic process(GO:0006558) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) |
0.1 | 0.8 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.1 | 0.5 | GO:0006183 | GTP biosynthetic process(GO:0006183) guanosine-containing compound biosynthetic process(GO:1901070) |
0.1 | 0.7 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.1 | 1.4 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.1 | 2.2 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.1 | 0.8 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.1 | 0.3 | GO:0007044 | cell-substrate junction assembly(GO:0007044) |
0.1 | 0.6 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) |
0.1 | 1.4 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.1 | 1.8 | GO:0032873 | negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
0.1 | 0.3 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
0.1 | 0.5 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.1 | 0.2 | GO:0015881 | creatine transport(GO:0015881) |
0.1 | 0.5 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.1 | 0.2 | GO:1902269 | positive regulation of polyamine transmembrane transport(GO:1902269) |
0.0 | 0.1 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.0 | 2.2 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.0 | 2.3 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.0 | 0.4 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.0 | 1.4 | GO:0034113 | heterotypic cell-cell adhesion(GO:0034113) |
0.0 | 0.1 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.0 | 0.1 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.0 | 1.2 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.0 | 0.3 | GO:0072641 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) type I interferon secretion(GO:0072641) interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
0.0 | 0.7 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 1.7 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.0 | 0.4 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.0 | 0.4 | GO:0033005 | positive regulation of mast cell activation(GO:0033005) |
0.0 | 4.9 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.0 | 0.8 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.0 | 1.1 | GO:0070266 | necroptotic process(GO:0070266) |
0.0 | 2.4 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
0.0 | 0.2 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
0.0 | 0.2 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.0 | 0.6 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.0 | 1.0 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.0 | 0.6 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.0 | 0.0 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.0 | 0.3 | GO:0033762 | response to glucagon(GO:0033762) |
0.0 | 1.1 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.0 | 0.3 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.0 | 0.1 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.0 | 0.7 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.0 | 0.3 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.0 | 0.7 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.0 | 0.9 | GO:0070168 | negative regulation of bone mineralization(GO:0030502) negative regulation of biomineral tissue development(GO:0070168) |
0.0 | 0.3 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
0.0 | 0.2 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.0 | 0.1 | GO:0061724 | lipophagy(GO:0061724) negative regulation of exosomal secretion(GO:1903542) |
0.0 | 0.1 | GO:0007225 | patched ligand maturation(GO:0007225) signal maturation(GO:0035638) |
0.0 | 0.6 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.3 | GO:0009249 | protein lipoylation(GO:0009249) |
0.0 | 0.3 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.0 | 0.6 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.0 | 0.2 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.0 | 0.4 | GO:0036035 | osteoclast development(GO:0036035) |
0.0 | 0.1 | GO:0043371 | negative regulation of CD4-positive, alpha-beta T cell differentiation(GO:0043371) negative regulation of T-helper cell differentiation(GO:0045623) negative regulation of alpha-beta T cell differentiation(GO:0046639) T follicular helper cell differentiation(GO:0061470) |
0.0 | 0.3 | GO:1903690 | regulation of wound healing, spreading of epidermal cells(GO:1903689) negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.0 | 0.8 | GO:0042304 | regulation of fatty acid biosynthetic process(GO:0042304) |
0.0 | 0.2 | GO:1904152 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) regulation of retrograde protein transport, ER to cytosol(GO:1904152) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.0 | 1.0 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.0 | 0.5 | GO:0031295 | T cell costimulation(GO:0031295) |
0.0 | 0.1 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.0 | 0.2 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.0 | 0.6 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.0 | 0.2 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.0 | 0.5 | GO:0006337 | nucleosome disassembly(GO:0006337) |
0.0 | 0.3 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.0 | 1.0 | GO:1901998 | toxin transport(GO:1901998) |
0.0 | 0.6 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.0 | 0.3 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.0 | 0.1 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.0 | 0.1 | GO:0046502 | uroporphyrinogen III metabolic process(GO:0046502) |
0.0 | 0.5 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.0 | 0.2 | GO:0070141 | response to UV-A(GO:0070141) |
0.0 | 0.1 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
0.0 | 0.3 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.0 | 0.0 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.0 | 0.4 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.0 | 1.1 | GO:0045638 | negative regulation of myeloid cell differentiation(GO:0045638) |
0.0 | 0.1 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.0 | 0.3 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.0 | 0.3 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.0 | 1.6 | GO:0030193 | regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
0.0 | 0.6 | GO:0018126 | protein hydroxylation(GO:0018126) |
0.0 | 0.7 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.0 | 3.7 | GO:0007160 | cell-matrix adhesion(GO:0007160) |
0.0 | 0.6 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.0 | 0.3 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.0 | 0.2 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.0 | 1.0 | GO:0030261 | chromosome condensation(GO:0030261) |
0.0 | 0.2 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.0 | 0.4 | GO:0045954 | positive regulation of natural killer cell mediated immunity(GO:0002717) positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.0 | 0.4 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.0 | 0.1 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.0 | 0.1 | GO:0001830 | trophectodermal cell fate commitment(GO:0001830) |
0.0 | 0.2 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.0 | 0.9 | GO:0042089 | cytokine biosynthetic process(GO:0042089) |
0.0 | 0.3 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.0 | 0.2 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.0 | 0.2 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.0 | 0.4 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
0.0 | 0.3 | GO:2000637 | positive regulation of gene silencing by miRNA(GO:2000637) |
0.0 | 0.8 | GO:0033006 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
0.0 | 0.4 | GO:0034389 | lipid particle organization(GO:0034389) |
0.0 | 0.1 | GO:0043102 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.0 | 0.1 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.0 | 3.8 | GO:0030833 | regulation of actin filament polymerization(GO:0030833) |
0.0 | 0.8 | GO:0045214 | sarcomere organization(GO:0045214) |
0.0 | 0.0 | GO:0003127 | detection of nodal flow(GO:0003127) detection of endogenous stimulus(GO:0009726) |
0.0 | 0.1 | GO:0009642 | response to light intensity(GO:0009642) |
0.0 | 0.2 | GO:0033622 | integrin activation(GO:0033622) |
0.0 | 0.5 | GO:0045582 | positive regulation of T cell differentiation(GO:0045582) |
0.0 | 0.2 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.0 | 0.1 | GO:0007527 | adult somatic muscle development(GO:0007527) |
0.0 | 0.4 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.0 | 0.1 | GO:0002279 | mast cell activation involved in immune response(GO:0002279) mast cell degranulation(GO:0043303) |
0.0 | 0.1 | GO:0016240 | autophagosome docking(GO:0016240) |
0.0 | 0.1 | GO:0009087 | methionine catabolic process(GO:0009087) |
0.0 | 0.1 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
0.0 | 1.0 | GO:0071356 | cellular response to tumor necrosis factor(GO:0071356) |
0.0 | 0.2 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.0 | 0.2 | GO:0015879 | carnitine transport(GO:0015879) |
0.0 | 0.1 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.0 | 0.1 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.0 | 0.2 | GO:0046326 | positive regulation of glucose import(GO:0046326) |
0.0 | 0.5 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.0 | 0.1 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.0 | 0.1 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.1 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.0 | 0.7 | GO:0032024 | positive regulation of insulin secretion(GO:0032024) |
0.0 | 0.4 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.0 | 0.1 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
0.0 | 0.1 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
0.0 | 0.1 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.0 | 0.3 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.0 | 0.3 | GO:0030903 | notochord development(GO:0030903) |
0.0 | 0.1 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.0 | 0.3 | GO:0019363 | pyridine nucleotide biosynthetic process(GO:0019363) |
0.0 | 0.2 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.0 | 0.3 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.0 | 0.2 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.0 | 0.3 | GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516) |
0.0 | 0.0 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.0 | 0.2 | GO:0006298 | mismatch repair(GO:0006298) |
0.0 | 0.1 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.0 | 0.7 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.0 | 0.3 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.0 | 0.2 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.0 | 0.1 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.0 | 0.4 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.4 | 11.9 | GO:0005914 | spot adherens junction(GO:0005914) |
1.3 | 3.9 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
1.0 | 58.0 | GO:0001533 | cornified envelope(GO:0001533) |
1.0 | 9.6 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.8 | 4.1 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.8 | 2.5 | GO:0061474 | phagolysosome membrane(GO:0061474) |
0.8 | 3.1 | GO:0044194 | cytolytic granule(GO:0044194) |
0.7 | 5.2 | GO:0005638 | lamin filament(GO:0005638) |
0.7 | 4.8 | GO:0071914 | prominosome(GO:0071914) |
0.7 | 2.0 | GO:1990630 | IRE1-RACK1-PP2A complex(GO:1990630) |
0.6 | 5.2 | GO:0097413 | Lewy body(GO:0097413) |
0.6 | 3.7 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.6 | 26.4 | GO:0045095 | keratin filament(GO:0045095) |
0.6 | 2.9 | GO:0071953 | elastic fiber(GO:0071953) |
0.5 | 2.1 | GO:0036284 | tubulobulbar complex(GO:0036284) |
0.5 | 2.6 | GO:0045160 | myosin I complex(GO:0045160) |
0.5 | 7.3 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.5 | 3.5 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.5 | 1.4 | GO:0005673 | transcription factor TFIIE complex(GO:0005673) |
0.4 | 1.3 | GO:0044317 | rod spherule(GO:0044317) |
0.4 | 1.2 | GO:0098592 | microspike(GO:0044393) cytoplasmic side of apical plasma membrane(GO:0098592) |
0.4 | 1.9 | GO:0030690 | Noc1p-Noc2p complex(GO:0030690) |
0.3 | 1.0 | GO:0043540 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex(GO:0043540) |
0.3 | 10.4 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.3 | 33.9 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.3 | 1.6 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.3 | 6.1 | GO:0005922 | connexon complex(GO:0005922) |
0.3 | 0.9 | GO:1990843 | subsarcolemmal mitochondrion(GO:1990843) interfibrillar mitochondrion(GO:1990844) |
0.3 | 0.6 | GO:0070820 | tertiary granule(GO:0070820) |
0.3 | 0.8 | GO:0097224 | sperm connecting piece(GO:0097224) |
0.3 | 0.8 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.3 | 0.8 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.2 | 0.5 | GO:0005607 | laminin-2 complex(GO:0005607) |
0.2 | 0.7 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.2 | 1.0 | GO:0031680 | G-protein beta/gamma-subunit complex(GO:0031680) |
0.2 | 2.9 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.2 | 4.6 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.2 | 1.4 | GO:0044218 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
0.2 | 2.3 | GO:1990462 | omegasome(GO:1990462) |
0.2 | 3.3 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.2 | 2.1 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.2 | 25.6 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.2 | 2.5 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.2 | 3.8 | GO:0042599 | lamellar body(GO:0042599) |
0.2 | 2.1 | GO:0005796 | Golgi lumen(GO:0005796) |
0.2 | 2.3 | GO:0001940 | male pronucleus(GO:0001940) |
0.2 | 1.7 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.2 | 3.4 | GO:0090543 | Flemming body(GO:0090543) |
0.2 | 1.5 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.2 | 5.6 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.2 | 0.7 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.2 | 1.1 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.2 | 1.2 | GO:1990246 | uniplex complex(GO:1990246) |
0.2 | 0.7 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.2 | 2.4 | GO:0036128 | CatSper complex(GO:0036128) |
0.2 | 0.5 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
0.2 | 0.8 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.2 | 1.5 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.2 | 2.4 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.2 | 0.5 | GO:0036020 | endolysosome membrane(GO:0036020) |
0.1 | 1.8 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 1.5 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.1 | 0.5 | GO:0045283 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.1 | 3.0 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 1.1 | GO:0001652 | granular component(GO:0001652) |
0.1 | 2.8 | GO:0042581 | specific granule(GO:0042581) |
0.1 | 0.4 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
0.1 | 0.4 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.1 | 1.5 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.1 | 0.3 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
0.1 | 0.9 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 0.6 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.1 | 8.0 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 1.3 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.1 | 0.8 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 3.3 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.1 | 0.3 | GO:0034679 | integrin alpha1-beta1 complex(GO:0034665) integrin alpha9-beta1 complex(GO:0034679) integrin alpha10-beta1 complex(GO:0034680) integrin alpha11-beta1 complex(GO:0034681) |
0.1 | 2.7 | GO:0010369 | chromocenter(GO:0010369) |
0.1 | 1.2 | GO:0000796 | condensin complex(GO:0000796) |
0.1 | 0.6 | GO:0031523 | Myb complex(GO:0031523) |
0.1 | 0.6 | GO:0070449 | elongin complex(GO:0070449) |
0.1 | 11.4 | GO:0005902 | microvillus(GO:0005902) |
0.1 | 0.4 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.1 | 0.3 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.1 | 0.4 | GO:0070442 | integrin alphaIIb-beta3 complex(GO:0070442) |
0.1 | 0.4 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.1 | 1.0 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 1.2 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 0.5 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.1 | 0.6 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.1 | 3.2 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 6.7 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 0.7 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.1 | 1.2 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 0.4 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 157.7 | GO:0005615 | extracellular space(GO:0005615) |
0.1 | 2.0 | GO:0008305 | integrin complex(GO:0008305) |
0.1 | 0.3 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.1 | 1.1 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.1 | 0.8 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.1 | 2.6 | GO:0016460 | myosin II complex(GO:0016460) |
0.1 | 0.3 | GO:0008623 | CHRAC(GO:0008623) |
0.1 | 0.8 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.1 | 3.4 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.1 | 1.1 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 0.3 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 1.2 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.1 | 0.5 | GO:0033503 | HULC complex(GO:0033503) |
0.1 | 10.9 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.1 | 0.2 | GO:0005605 | basal lamina(GO:0005605) |
0.1 | 1.1 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 4.3 | GO:0005882 | intermediate filament(GO:0005882) |
0.1 | 0.3 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.1 | 2.6 | GO:0015030 | Cajal body(GO:0015030) |
0.1 | 1.2 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 6.3 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 1.8 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 0.6 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 1.2 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 7.4 | GO:0005903 | brush border(GO:0005903) |
0.0 | 0.5 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 0.3 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.8 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.0 | 0.5 | GO:0060091 | kinocilium(GO:0060091) |
0.0 | 1.2 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.0 | 0.2 | GO:0031983 | vesicle lumen(GO:0031983) |
0.0 | 1.5 | GO:0002102 | podosome(GO:0002102) |
0.0 | 2.0 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.0 | 0.6 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.0 | 0.3 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.0 | 5.9 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 1.5 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.5 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.0 | 0.5 | GO:0044453 | nuclear membrane part(GO:0044453) |
0.0 | 1.2 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.0 | 7.4 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.1 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.0 | 0.6 | GO:0005861 | troponin complex(GO:0005861) |
0.0 | 1.1 | GO:0031902 | late endosome membrane(GO:0031902) |
0.0 | 1.7 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.0 | 0.1 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.0 | 0.9 | GO:0000786 | nucleosome(GO:0000786) DNA packaging complex(GO:0044815) |
0.0 | 0.1 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.0 | 0.4 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.0 | 0.2 | GO:0005827 | polar microtubule(GO:0005827) |
0.0 | 1.7 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.5 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.0 | 0.3 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.0 | 0.4 | GO:0097470 | ribbon synapse(GO:0097470) |
0.0 | 0.3 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.1 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
0.0 | 1.6 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.0 | 1.5 | GO:0030175 | filopodium(GO:0030175) |
0.0 | 0.0 | GO:0070992 | translation initiation complex(GO:0070992) |
0.0 | 1.1 | GO:0005876 | spindle microtubule(GO:0005876) |
0.0 | 0.4 | GO:0043218 | compact myelin(GO:0043218) |
0.0 | 0.1 | GO:0044299 | C-fiber(GO:0044299) |
0.0 | 0.3 | GO:0042555 | MCM complex(GO:0042555) |
0.0 | 0.1 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.0 | 0.2 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.0 | 0.8 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.0 | 0.1 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.0 | 0.8 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 0.3 | GO:0051233 | spindle midzone(GO:0051233) |
0.0 | 0.3 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
0.0 | 0.1 | GO:0032009 | early phagosome(GO:0032009) |
0.0 | 0.8 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 0.1 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.6 | 10.4 | GO:0005008 | hepatocyte growth factor-activated receptor activity(GO:0005008) |
2.2 | 6.5 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
1.9 | 5.6 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
1.6 | 4.8 | GO:0052600 | diamine oxidase activity(GO:0052597) histamine oxidase activity(GO:0052598) methylputrescine oxidase activity(GO:0052599) propane-1,3-diamine oxidase activity(GO:0052600) |
1.5 | 4.6 | GO:0042936 | dipeptide transporter activity(GO:0042936) |
1.5 | 8.7 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
1.4 | 8.5 | GO:1990254 | keratin filament binding(GO:1990254) |
1.4 | 4.2 | GO:0070540 | stearic acid binding(GO:0070540) |
1.4 | 4.1 | GO:0035731 | S-nitrosoglutathione binding(GO:0035730) dinitrosyl-iron complex binding(GO:0035731) |
1.2 | 3.6 | GO:0031768 | ghrelin receptor binding(GO:0031768) |
1.2 | 4.8 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
1.1 | 3.4 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
1.1 | 6.6 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
1.0 | 3.1 | GO:0052870 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) |
0.9 | 24.5 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.9 | 3.7 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.9 | 3.6 | GO:0019862 | IgA binding(GO:0019862) |
0.9 | 2.6 | GO:0033971 | hydroxyisourate hydrolase activity(GO:0033971) |
0.9 | 4.3 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.8 | 0.8 | GO:0048030 | disaccharide binding(GO:0048030) |
0.8 | 3.4 | GO:0047874 | dolichyldiphosphatase activity(GO:0047874) |
0.8 | 7.5 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.8 | 6.5 | GO:0017040 | ceramidase activity(GO:0017040) |
0.8 | 13.0 | GO:0019841 | retinol binding(GO:0019841) |
0.8 | 3.1 | GO:0047016 | cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity(GO:0047016) |
0.7 | 3.6 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
0.7 | 2.1 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.7 | 2.6 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.7 | 6.5 | GO:0038132 | neuregulin binding(GO:0038132) |
0.6 | 3.8 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.6 | 1.9 | GO:0008127 | quercetin 2,3-dioxygenase activity(GO:0008127) |
0.6 | 2.5 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.6 | 1.8 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
0.6 | 7.3 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.6 | 2.4 | GO:0004063 | aryldialkylphosphatase activity(GO:0004063) |
0.6 | 1.8 | GO:0019002 | GMP binding(GO:0019002) |
0.6 | 1.8 | GO:0035717 | chemokine (C-C motif) ligand 7 binding(GO:0035717) |
0.6 | 18.8 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.6 | 2.3 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.5 | 1.6 | GO:0033680 | ATP-dependent DNA/RNA helicase activity(GO:0033680) |
0.5 | 0.5 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.5 | 3.2 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.5 | 1.6 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.5 | 2.0 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.5 | 2.5 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
0.5 | 3.4 | GO:0030549 | acetylcholine receptor activator activity(GO:0030549) |
0.5 | 1.4 | GO:0031751 | D4 dopamine receptor binding(GO:0031751) |
0.5 | 1.4 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.5 | 1.9 | GO:0005118 | sevenless binding(GO:0005118) |
0.5 | 1.9 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
0.5 | 1.9 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
0.5 | 1.4 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
0.5 | 1.8 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.5 | 1.4 | GO:0008775 | acetate CoA-transferase activity(GO:0008775) |
0.5 | 4.1 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.4 | 4.0 | GO:0016936 | galactoside binding(GO:0016936) |
0.4 | 1.3 | GO:0052593 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
0.4 | 4.4 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.4 | 1.3 | GO:0002055 | adenine binding(GO:0002055) adenine phosphoribosyltransferase activity(GO:0003999) |
0.4 | 5.1 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.4 | 5.0 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.4 | 7.3 | GO:0046977 | TAP binding(GO:0046977) |
0.4 | 1.2 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
0.4 | 2.3 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.4 | 11.5 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.4 | 1.1 | GO:0008520 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
0.3 | 2.1 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.3 | 4.5 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.3 | 1.4 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.3 | 0.3 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.3 | 2.0 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.3 | 2.3 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.3 | 1.3 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
0.3 | 1.6 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.3 | 1.3 | GO:0036468 | aromatic-L-amino-acid decarboxylase activity(GO:0004058) L-dopa decarboxylase activity(GO:0036468) |
0.3 | 2.5 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.3 | 0.9 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.3 | 3.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.3 | 2.8 | GO:0017050 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
0.3 | 0.9 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
0.3 | 10.3 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
0.3 | 0.9 | GO:0008119 | thiopurine S-methyltransferase activity(GO:0008119) |
0.3 | 8.2 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.3 | 1.8 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.3 | 2.6 | GO:0015643 | toxic substance binding(GO:0015643) |
0.3 | 0.9 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.3 | 1.1 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.3 | 0.8 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.3 | 8.5 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.3 | 1.1 | GO:0015403 | thiamine uptake transmembrane transporter activity(GO:0015403) |
0.3 | 3.3 | GO:0050700 | CARD domain binding(GO:0050700) |
0.3 | 5.4 | GO:0001968 | fibronectin binding(GO:0001968) |
0.3 | 1.9 | GO:0030172 | troponin C binding(GO:0030172) troponin I binding(GO:0031013) |
0.3 | 4.0 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.3 | 20.3 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.3 | 0.8 | GO:0042602 | riboflavin reductase (NADPH) activity(GO:0042602) |
0.3 | 0.8 | GO:0004371 | glycerone kinase activity(GO:0004371) FAD-AMP lyase (cyclizing) activity(GO:0034012) triokinase activity(GO:0050354) |
0.3 | 0.8 | GO:0047316 | L-phenylalanine:pyruvate aminotransferase activity(GO:0047312) glutamine-phenylpyruvate transaminase activity(GO:0047316) L-glutamine:pyruvate aminotransferase activity(GO:0047945) |
0.3 | 8.0 | GO:0070330 | aromatase activity(GO:0070330) |
0.3 | 2.8 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.3 | 0.8 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.3 | 1.5 | GO:0070728 | leucine binding(GO:0070728) |
0.2 | 2.2 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.2 | 1.4 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.2 | 0.9 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.2 | 4.7 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.2 | 1.2 | GO:0048495 | Roundabout binding(GO:0048495) |
0.2 | 1.6 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
0.2 | 0.7 | GO:0004915 | interleukin-6 receptor activity(GO:0004915) interleukin-6 binding(GO:0019981) |
0.2 | 1.6 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.2 | 9.1 | GO:0043236 | laminin binding(GO:0043236) |
0.2 | 0.7 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.2 | 0.9 | GO:0072354 | histone kinase activity (H3-T3 specific)(GO:0072354) |
0.2 | 1.5 | GO:0045545 | syndecan binding(GO:0045545) |
0.2 | 5.0 | GO:0005537 | mannose binding(GO:0005537) |
0.2 | 0.9 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
0.2 | 5.5 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.2 | 1.5 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.2 | 1.9 | GO:0004568 | chitinase activity(GO:0004568) |
0.2 | 0.6 | GO:0045159 | myosin II binding(GO:0045159) |
0.2 | 1.8 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.2 | 1.0 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.2 | 3.9 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.2 | 1.4 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.2 | 1.5 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.2 | 1.5 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.2 | 1.5 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.2 | 1.1 | GO:0034618 | arginine binding(GO:0034618) |
0.2 | 1.3 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.2 | 2.6 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.2 | 0.5 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
0.2 | 0.5 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
0.2 | 42.0 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.2 | 1.4 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.2 | 2.6 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.2 | 1.7 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.2 | 9.9 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.2 | 1.6 | GO:0016672 | oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor(GO:0016672) |
0.2 | 7.0 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.2 | 1.2 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.2 | 0.5 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.2 | 21.9 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.2 | 0.7 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.2 | 6.9 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.2 | 2.3 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.2 | 2.6 | GO:0019956 | chemokine binding(GO:0019956) |
0.2 | 1.0 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.2 | 1.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.2 | 0.5 | GO:0052642 | lysophosphatidic acid phosphatase activity(GO:0052642) |
0.2 | 0.8 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.2 | 1.3 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.2 | 0.5 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.2 | 0.8 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.2 | 3.0 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.2 | 3.3 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.2 | 0.6 | GO:0004103 | choline kinase activity(GO:0004103) |
0.2 | 23.8 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.2 | 2.7 | GO:0044548 | S100 protein binding(GO:0044548) |
0.2 | 1.7 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.1 | 0.4 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.1 | 0.7 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.1 | 0.4 | GO:0016034 | maleylacetoacetate isomerase activity(GO:0016034) |
0.1 | 2.5 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 1.7 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.1 | 1.0 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.1 | 1.4 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.1 | 1.5 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.1 | 0.8 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.1 | 0.5 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.1 | 1.0 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.1 | 0.9 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.1 | 0.6 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.1 | 0.9 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.1 | 3.5 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.1 | 0.6 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.1 | 0.4 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.1 | 0.7 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.1 | 1.4 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.1 | 0.6 | GO:0004925 | prolactin receptor activity(GO:0004925) |
0.1 | 0.4 | GO:0002058 | uracil binding(GO:0002058) pyrimidine nucleobase binding(GO:0002061) |
0.1 | 0.5 | GO:0030294 | receptor signaling protein tyrosine kinase inhibitor activity(GO:0030294) |
0.1 | 2.8 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.1 | 0.6 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.1 | 0.8 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.1 | 2.8 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.1 | 1.9 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.1 | 0.5 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.1 | 1.8 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.5 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
0.1 | 1.8 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 0.4 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity(GO:0035539) |
0.1 | 0.8 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.1 | 2.1 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.5 | GO:0047726 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) iron-cytochrome-c reductase activity(GO:0047726) |
0.1 | 2.3 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 1.0 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.1 | 19.3 | GO:0008083 | growth factor activity(GO:0008083) |
0.1 | 0.5 | GO:0008311 | double-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008311) |
0.1 | 9.2 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 0.3 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 0.3 | GO:0001607 | neuromedin U receptor activity(GO:0001607) |
0.1 | 2.0 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 1.9 | GO:0042287 | MHC protein binding(GO:0042287) |
0.1 | 0.6 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.1 | 0.5 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 0.7 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 2.5 | GO:0051861 | glycolipid binding(GO:0051861) |
0.1 | 0.7 | GO:0055104 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
0.1 | 2.3 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 2.4 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 3.0 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.1 | 0.5 | GO:0070287 | ferritin receptor activity(GO:0070287) |
0.1 | 2.6 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 0.4 | GO:0030156 | benzodiazepine receptor binding(GO:0030156) |
0.1 | 1.0 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.1 | 0.7 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.1 | 14.2 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 1.9 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.1 | 1.0 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.1 | 3.7 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.1 | 2.9 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.1 | 2.0 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 3.5 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.1 | 0.4 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
0.1 | 0.4 | GO:0003681 | bent DNA binding(GO:0003681) |
0.1 | 5.2 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 0.3 | GO:0016784 | 3-mercaptopyruvate sulfurtransferase activity(GO:0016784) |
0.1 | 1.6 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 0.8 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 1.2 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.1 | 0.4 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.1 | 0.3 | GO:0050262 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
0.1 | 0.7 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.1 | 1.7 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 0.7 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.1 | 0.5 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.1 | 0.8 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.1 | 0.5 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.1 | 0.5 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 0.9 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.1 | 0.2 | GO:0004342 | glucosamine-6-phosphate deaminase activity(GO:0004342) |
0.1 | 0.2 | GO:0005009 | insulin-activated receptor activity(GO:0005009) |
0.1 | 0.5 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 0.4 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.1 | 1.2 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 0.9 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 0.7 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.1 | 0.2 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.1 | 0.8 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.1 | 0.3 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 0.2 | GO:0008431 | vitamin E binding(GO:0008431) |
0.1 | 0.6 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 0.2 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
0.1 | 3.2 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.6 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 0.3 | GO:0030984 | kininogen binding(GO:0030984) |
0.1 | 2.0 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 0.6 | GO:0036122 | BMP binding(GO:0036122) |
0.1 | 3.2 | GO:0005504 | fatty acid binding(GO:0005504) |
0.1 | 0.8 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.1 | 2.9 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 1.9 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 0.4 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.1 | 1.0 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.1 | 0.6 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 0.1 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.1 | 1.2 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.1 | 0.2 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
0.1 | 7.6 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.1 | 6.6 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.1 | 1.2 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.1 | 1.7 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.2 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.1 | 0.3 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 0.3 | GO:0004452 | isopentenyl-diphosphate delta-isomerase activity(GO:0004452) |
0.1 | 0.3 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.1 | 1.6 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.1 | 6.0 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.1 | 0.4 | GO:0042731 | PH domain binding(GO:0042731) |
0.1 | 2.1 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 0.9 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.1 | 31.0 | GO:0005198 | structural molecule activity(GO:0005198) |
0.1 | 0.2 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) bradykinin receptor binding(GO:0031711) |
0.1 | 0.3 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.1 | 0.2 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.1 | 0.2 | GO:0005308 | creatine transmembrane transporter activity(GO:0005308) |
0.1 | 0.2 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.0 | 0.4 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.0 | 0.7 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.0 | 1.6 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.0 | 5.0 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.0 | 1.2 | GO:0031491 | nucleosome binding(GO:0031491) |
0.0 | 1.4 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.0 | 0.2 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.0 | 0.3 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.0 | 0.3 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.0 | 0.3 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
0.0 | 0.0 | GO:0016005 | phospholipase A2 activator activity(GO:0016005) |
0.0 | 0.1 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 0.3 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.0 | 0.3 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.3 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.0 | 0.8 | GO:0016594 | glycine binding(GO:0016594) |
0.0 | 0.6 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.0 | 0.8 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.1 | GO:0031531 | thyrotropin-releasing hormone receptor binding(GO:0031531) |
0.0 | 0.8 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.0 | 13.7 | GO:0045296 | cadherin binding(GO:0045296) |
0.0 | 0.6 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.0 | 1.4 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.0 | 1.1 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 2.2 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.0 | 0.4 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.0 | 0.4 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 0.3 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.0 | 0.2 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.0 | 0.2 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.0 | 0.2 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.0 | 0.2 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) hemi-methylated DNA-binding(GO:0044729) |
0.0 | 0.2 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.0 | 0.5 | GO:0031996 | thioesterase binding(GO:0031996) |
0.0 | 0.8 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 2.7 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 0.5 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.8 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.0 | 1.5 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 1.5 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.0 | 0.3 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.0 | 0.4 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.0 | 0.3 | GO:0016505 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) peptidase activator activity involved in apoptotic process(GO:0016505) |
0.0 | 5.5 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 1.2 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.0 | 2.4 | GO:0035326 | enhancer binding(GO:0035326) |
0.0 | 0.1 | GO:0004819 | glutamine-tRNA ligase activity(GO:0004819) |
0.0 | 0.6 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.0 | 0.1 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.0 | 0.1 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.0 | 3.2 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
0.0 | 1.7 | GO:0005319 | lipid transporter activity(GO:0005319) |
0.0 | 3.4 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.4 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.0 | 0.1 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.0 | 0.3 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.0 | 0.1 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.0 | 0.1 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.0 | 0.2 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.0 | 0.9 | GO:0043621 | protein self-association(GO:0043621) |
0.0 | 0.4 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.0 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.0 | 0.5 | GO:0016675 | oxidoreductase activity, acting on a heme group of donors(GO:0016675) |
0.0 | 0.5 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.0 | 0.0 | GO:0016295 | oleoyl-[acyl-carrier-protein] hydrolase activity(GO:0004320) myristoyl-[acyl-carrier-protein] hydrolase activity(GO:0016295) palmitoyl-[acyl-carrier-protein] hydrolase activity(GO:0016296) acyl-[acyl-carrier-protein] hydrolase activity(GO:0016297) |
0.0 | 0.2 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.0 | 0.1 | GO:0004905 | interferon receptor activity(GO:0004904) type I interferon receptor activity(GO:0004905) type I interferon binding(GO:0019962) |
0.0 | 1.5 | GO:0005262 | calcium channel activity(GO:0005262) |
0.0 | 0.1 | GO:0004478 | methionine adenosyltransferase activity(GO:0004478) |
0.0 | 3.0 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.0 | 0.1 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.0 | 0.4 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.3 | GO:0019840 | isoprenoid binding(GO:0019840) |
0.0 | 0.2 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 0.1 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.0 | 0.2 | GO:0008143 | poly(A) binding(GO:0008143) |
0.0 | 0.3 | GO:0070064 | proline-rich region binding(GO:0070064) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 7.9 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.3 | 23.3 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.3 | 21.5 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.2 | 49.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.2 | 4.1 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.2 | 10.4 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.2 | 0.2 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.2 | 5.5 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 6.2 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 3.0 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 8.6 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.1 | 17.5 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 6.4 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 7.3 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 5.1 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 1.5 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.1 | 1.5 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 3.4 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 4.9 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 1.0 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 1.5 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 25.5 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 8.4 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 5.2 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 5.3 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 0.8 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 2.1 | PID IGF1 PATHWAY | IGF1 pathway |
0.1 | 0.8 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 1.3 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 0.8 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.1 | 10.9 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 16.8 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 1.6 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 0.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 1.6 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.7 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.7 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.4 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 1.1 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 4.2 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.9 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 1.8 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 0.9 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 1.1 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.5 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.3 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 1.2 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 2.2 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 1.4 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 1.0 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.6 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.9 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 0.9 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.0 | 0.5 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.7 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.4 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 0.5 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 0.8 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 0.2 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.1 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 0.3 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.1 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.2 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 24.8 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.6 | 6.4 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.5 | 9.6 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.5 | 8.5 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.4 | 16.9 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.3 | 9.7 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.3 | 7.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.3 | 3.3 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.3 | 6.9 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.3 | 3.9 | REACTOME DEFENSINS | Genes involved in Defensins |
0.3 | 6.6 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.3 | 12.3 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.2 | 5.1 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.2 | 2.9 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.2 | 4.0 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.2 | 3.8 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.2 | 3.6 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.2 | 2.8 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.2 | 0.8 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.2 | 9.3 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.2 | 8.6 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.2 | 1.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.2 | 0.5 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.2 | 7.6 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.2 | 6.3 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.2 | 2.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.2 | 13.2 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.2 | 1.7 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 6.4 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.1 | 4.6 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.1 | 6.0 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 1.8 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.1 | 2.2 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 6.5 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 0.3 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.1 | 3.2 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.1 | 1.3 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 0.8 | REACTOME ORC1 REMOVAL FROM CHROMATIN | Genes involved in Orc1 removal from chromatin |
0.1 | 0.9 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 1.9 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.1 | 1.4 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.1 | 0.6 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 10.7 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.1 | 2.5 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 1.5 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.1 | 3.6 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.1 | 3.5 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 3.5 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.1 | 0.8 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.1 | 2.0 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.1 | 1.1 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 1.5 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 1.1 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.1 | 2.0 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.1 | 0.7 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 3.4 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 1.3 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 1.1 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 1.5 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.1 | 5.0 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 3.3 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 1.3 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 0.9 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 1.3 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 1.0 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 2.8 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.1 | 2.6 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 1.2 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 0.7 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.1 | 2.2 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 0.8 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.0 | 1.4 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 2.1 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 0.2 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 1.7 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.9 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.0 | 1.1 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 1.1 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 2.7 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.4 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 0.5 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.0 | 0.9 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 0.2 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.3 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.0 | 0.8 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 0.5 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 0.7 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.3 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.0 | 0.9 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.4 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.2 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.0 | 1.2 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.0 | 0.5 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.0 | 0.2 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.5 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.4 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.3 | REACTOME BIOLOGICAL OXIDATIONS | Genes involved in Biological oxidations |
0.0 | 1.1 | REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE | Genes involved in MyD88:Mal cascade initiated on plasma membrane |
0.0 | 0.4 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.0 | 0.2 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.3 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 0.2 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.0 | 1.2 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.4 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 0.6 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.0 | 0.2 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.0 | 0.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.2 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 0.2 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.5 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.8 | REACTOME TRANSLATION | Genes involved in Translation |
0.0 | 0.0 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |